Updates

Scapa - Now a 10-bagger since 2011

July 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The shares became a 10-bagger during the month. Who would have thought it would happen so quickly when we made the shares a main Buy at 47p in November ’11. Even 12 months ago they could have been had at 160p.Of course, regular readers to SCSW will know about the massive transformation that has taken place as Scapa has moved away from making tapes in commoditised areas of the automotive and construction sectors and into the medical sector. Latest results show this process continuing and beat even recently upgraded expectations. Sales went up 13% to £279.6m but adjusted pretax profit increased 36% to £28m and helped by low tax, eps rose 42% to 14.2p.Net debt was £16m after spending £28.3m on the a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Boohoo.com - Gain to date: 680%

Kainos

Scapa - Factories "essential business" status (April 2020)

Scapa (December 2018)

Scapa (November 2017)

Scapa (November 2016)

Scapa - Debt down massively (May 2016)

Scapa (January 2016)

Scapa (November 2015)

Scapa (June 2015)

Scapa - Third profit upgrade since November (May 2015)

Scapa - £11.3m healthcare acquisition (April 2015)

Scapa - Moves to 24/7 shift working on healthcare side (July 2014)

Scapa - Healthcare side margins rocket (January 2014)

Scapa - Talks with Tapex (Korea) may resume (July 2013)

Scapa (December 2012)

Scapa (November 2012)

Scapa - Going to beat market forecasts (May 2012)

Scapa - Buys US adhesive-backed woundcare manufacturer (March 2012)

Scapa - New markets in medical and electronic tapes look good (November 2011)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X